Publications

  1. Home
  2. chevron_right
  3. Publications

2024

Duncanson K, Williams G, Hoedt E. C, Collins C. E, Keely S, & Talley N. J. Diet-microbiota associations in gastrointestinal research: a systematic review. 2024. Gut Microbes16(1). https://doi.org/10.1080/19490976.2024.2350785

Hirano I, Dellon ES, Falk GW, Gonsalves NP, Furuta GT, Bredenoord AJ, Straumann A, Schoepfer A, Chang JW, Peterson K, Talley NJ. Ascending To New Heights For Novel Therapeutics For Eosinophilic Esophagitis. Gastroenterology. 2024 Jan 1;166(1):1-0.

Zuzek R, Potter M, Talley NJ, Agréus L, Andreasson A, Veits L, Vieth M, Walker MM. Prevalence Of Histological Gastritis In A Community Population And Association With Epigastric Pain. Digestive diseases and sciences. 2024 Feb;69(2):528-37.

Koloski N, Shah A, Kaan I, Ben Jacob R, Talley NJ, Jones MP, Holtmann G. Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. 2024 Feb 24:1-0.

Jones MP, Koloski NA, Walker MM, Holtmann GJ, Shah A, Eslick GD, Talley NJ. A Minority Of Childhood Disorders Of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis. Am J Gastroenterol. Published online March 14, 2024. doi:10.14309/ajg.0000000000002751

Koloski N, Duncanson K, Ramanathan SA, Rao M, Holtmann G, Talley NJ. What Impact Has The Centre Of Research Excellence In Digestive Health Made In The Field Of Gastrointestinal Health In Australia And Internationally? Study Protocol For Impact Evaluation Using The Fait Framework. BMJ Open. 2024;14(3):e076839. Published 2024 Mar 21. doi:10.1136/bmjopen-2023-076839

Zamani M, Alizadeh-Tabari S, Murad MH, Ananthakrishnan AN, Malekzadeh R, Talley NJ. Meta-Analysis: Risk Of Pancreatic Cancer In Patients With Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2024;59(8):918-927. doi:10.1111/apt.17919

2023

Abell TL, Kuo B, Esfandyari T, Pfeifer ND, Grimaldi M, Renzulli C, Tacchi R, Zhou K, Barnes CN, Nguyen DD, Nguyen L. A Randomized, Double‐blind, Placebo‐controlled, Phase 2b Study Of The Efficacy And Safety Of Velusetrag In Subjects With Diabetic Or Idiopathic Gastroparesis. Neurogastroenterology & Motility. 2023 Apr;35(4):e14523.

Alexandersson BT, Hugerth LW, Hedin C, Forsberg A, Talley NJ, Agreus L, Järbrink-Sehgal E, Engstrand L, Andreasson A, Schmidt PT. Diverticulosis Is Not Associated With Altered Gut Microbiota Nor Is It Predictive Of Future Diverticulitis: A Population-Based Colonoscopy Study. Scandinavian journal of gastroenterology. 2023 Oct 3;58(10):1131-8.

Ali AH, Buness CW, Fischer R, Holtmann GJ, Shah A, Lewindon P, Shah S, Ragnekar AS, Taylor AE, Goel A, Cox KL, Alrabadi L, Wadsworth S, Kulkarni SS, Lindor KD. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 Jan 30. doi: 10.1097/HEP.0000000000000304. Epub ahead of print. PMID: 36705026.

Burns GL, Bruce JK, Minahan K, Mathe A, Fairlie T, Cameron R, Naudin C, Nair PM, Potter MDE, Irani MZ, Bollipo S, Foster R, Gan LT, Shah A, Koloski NA, Foster PS, Horvat JC, Veysey M, Holtmann G, Powell N, Walker MM, Talley NJ, Keely S. Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia. Front Immunol.2023 Jan 6;13:1051632. doi: 10.3389/fimmu.2022.1051632. PMID: 36685573; PMCID:

Burns GL, Potter M, Mathe A, Bruce J, Minahan K, Barnes JL, Pryor J, Nieva C, Sherwin S, Cuskelly A, Fairlie T, Cameron R, Bollipo S, Zand Irani M, Foster R, Gan LT, Shah A, Koloski N, Foster PS, Horvat JC, Walker MM, Powell N, Veysey M, Duncanson K, Holtmann G, Talley NJ, Keely S. TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional Dyspepsia. Clin Transl Gastroenterol. 2023;14(12):e00638. Published 2023 Dec 1. doi:10.14309/ctg.0000000000000638

Cameron R, Duncanson K, Hoedt EC, Eslick GD, Burns GL, Nieva C, Keely S, Walker MM, Talley NJ. Does the microbiome play a role in the pathogenesis of colonic diverticular disease? A systematic review. Journal of gastroenterology and hepatology. 2023 Feb 12.

Cameron R, Walker MM, Jones M, Eslick GD, Keely S, Pockney P, Cosentino CC, Talley NJ. Increased mucosal eosinophils in colonic diverticulosis and diverticular disease. Journal of Gastroenterology and Hepatology. 2023 Aug;38(8):1355-64.

Donnelly MC, Talley NJ. Effects of climate change on digestive health and preventative measures. Gut. 2023 Dec 1;72(12):2199-201.

Duncanson K, Tikhe D, Williams GM, Talley NJ. Irritable bowel syndrome – controversies in diagnosis and management. Expert Rev Gastroenterol Hepatol. 2023;17(7):649-663. doi:10.1080/17474124.2023.2223975

Eslick GD, Fan K, Nair PM, Burns GL, Hoedt EC, Keely S, Talley NJ. Clinical and Pathologic Factors Associated With Colonic Spirochete (Brachyspira pilosicoli and Brachyspira aalborgi) Infection: A Comprehensive Systematic Review and Pooled Analysis. American journal of clinical pathology. 2023 Oct 1;160(4):335-40.

Fairlie T, Shah A, Talley NJ, Chey WD, Koloski N, Lee YY, Gwee KA, Jones MP, Holtmann G. Overlap of disorders of gut–brain interaction: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2023 May 18.

Ghoshal UC, Ghoshal U, Shah A, Holtmann G. Evaluation of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology. 2023 May 4;17(5):461-7.

Gwee KA, Lee YY, Suzuki H, Ghoshal UC, Holtmann G, Bai T, Barbara G, Chen MH, Chua AS, Gibson PR, Hou X. Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms. Journal of Gastroenterology and Hepatology. 2023 Feb;38(2):197-209.

Hammer J, Holtmann G, Hammer K. Validation of the Structured Assessment of Gastrointestinal Symptoms Scale to Support Standardized Evaluation and Follow-up. Journal of Pediatric Gastroenterology and Nutrition. 2023 May 10.

Huang IH, Schol J, Carbone F, Chen YJ, Van den Houte K, Balsiger LM, Broeders B, Vanuytsel T, Tack J. Prevalence of delayed gastric emptying in patients with gastroparesis-like symptoms. Aliment Pharmacol Ther. 2023 Jan 10. doi: 10.1111/apt.17330. Epub ahead of print. PMID: 36625491.

James SC, Fraser K, Cooney J, Günther CS, Young W, Gearry RB, Heenan PE, Trower T, Keenan JI, Talley NJ, McNabb WC. Concentrations of plasma amino acids and neurotransmitters in participants with functional gut disorders and healthy controls. Metabolites. 2023 Feb 20;13(2):313.

Jones MP, Guthrie-Lyons L, Sato YA, Talley NJ. Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials. Am J Gastroenterol. 2023;118(4):685-691. doi:10.14309/ajg.0000000000002097

Jones MP, Holtmann G. Placebo effects in functional dyspepsia: Causes and implications for clinical trials. Neurogastroenterology & Motility. 2023 Feb;35(2):e14527.

Kutyla MJ, McMaster JJ, Haig A, Koloski N, Hourigan L, Meeusen V, Shah A, Talley NJ, Jones MP, Holtmann G. Development and Validation of a Patient-Reported Experience Measure for Gastrointestinal Endoscopy: The Comprehensive Endoscopy Satisfaction Tool (CEST). Journal of Clinical Gastroenterology. 2023 May 1:10-97.

Lim AW, Talley NJ, Walker MM, Storm G, Hua S. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors. Drug delivery. 2023 Dec 31;30(1):2219423.

MacIntosh A, Heenan PE, Wright-McNaughton M, Frampton C, Skidmore P, Wall CL, Muir J, Talley NJ, Roy NC, Gearry RB. The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders. Frontiers in Nutrition. 2023 Feb 2;10:1060928.

Marinucci N, Moy N, Koloski N, Shah A, Austin G, Russell‐Bennett R, McGraw J, Dulleck U, Holtmann G. Social Determinants and Participation in Fecal Occult Blood Test Based Colorectal Cancer Screening: A Qualitative Systematic Review and Meta‐Synthesis. Health Promotion Journal of Australia. 2023 Apr 11.

McCarthy H, Keely S. Re-evaluating the Role of Deep Crypt Secretory Cells in Intestinal Homeostasis. Cellular and molecular gastroenterology and hepatology. 2023;15(4):1020.

Melton SL, Fitzpatrick JA, Taylor KM, Halmos EP, Gibson PR. Lessons from an audit of exclusive enteral nutrition in adult inpatients and outpatients with active Crohn’s disease: A single-centre experience. Frontline Gastroenterology. 2023 Jan;14(1). https://doi.org/10.1136/flgastro-2022-102173

Nguyen PV, Quach DT, Bui MH, Dang TP, Talley NJ. A Clinicopathologic Continuum of Eosinophilic Gastrointestinal Diseases in an Adult With Tuberculosis and Latent Hepatitis B Virus Infection. ACG Case Reports Journal. 2023 Oct 1;10(10):e01176.

Nieva C, Pryor J, Williams GM, Hoedt EC, Burns GL, Eslick GD, Talley NJ, Duncanson K, Keely S. The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn’s and Colitis. 2023 Dec 15:jjad204.

Shah A, Eqbal A, Moy N, Koloski N, Messman H, Kendall BJ, Sharma P, Dulleck U, Jones MP, Holtmann G. Upper Gastrointestinal Endoscopy in Subjects with Positive Faecal Occult Blood Test Undergoing Colonoscopy: Systematic Review and Meta-Analysis. Gastrointestinal Endoscopy. 2023 Feb 20.

Shah A, Ghoshal UC, Holtmann G. Unravelling the controversy with small intestinal bacterial overgrowth. Current Opinion in Gastroenterology. 2023 May 1;39(3):211-8.

Shah A, Pakeerathan V, Jones MP, Kashyap PC, Virgo K, Fairlie T, Morrison M, Ghoshal UC, Holtmann G. Small Intestinal Bacterial Overgrowth Complicating Gastrointestinal Manifestations of Systemic Sclerosis: A Systematic Review and Meta-analysis. Journal of Neurogastroenterology and Motility. 2023 Apr 4;29(2):132.

Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, Bristow TC, Heng J, Gupta A, Ovenden C, Maddern G. Weight loss with subcutaneous semaglutide versus other glucagon‐like peptide 1 receptor agonists in type 2 diabetes: a systematic review. Internal medicine journal. 2023 Aug;53(8):1311-20.

Talley NJ, Burns GL, Hoedt EC, Duncanson K, Keely S. Beyond Eosinophilic Esophagitis: Eosinophils in Gastrointestinal Disease—New Insights,“New” Diseases. Journal of the Canadian Association of Gastroenterology. 2023 Dec 1;6(6):199-211.

Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, Lacy BE, Chehade M, Hirano I, Gonsalves N, Lembo A. High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate–Severe Abdominal Symptoms: A Prospective US Multisite Study. Gastroenterology. 2023 Apr 1;164(4):680-3.

Vishnoi V, Hoedt EC, Gould T, Carroll G, Carroll R, Lott N, Pockney P, Smith SR, Keely S. A pilot study: intraoperative 16S rRNA sequencing versus culture in predicting colorectal incisional surgical site infection. ANZ journal of surgery. 2023 Apr 6.

Vishnoi V, Morey T, Hoedt EC, Keely S, Pockney P, Smith SR. A Systematic Review and Meta-Analysis of Intra-Operative Surgical Site Sampling: Culture versus Culture-Independent Techniques in Predicting Downstream Surgical Site Infection. Surgical infections. 2023 May 1;24(4):293-302.

Wauters L, Harris PR, Walker MM, Serrano CA, Villagrán A, Rakhra GS, Crabtree JE, Talley NJ. Childhood recurrent abdominal pain is associated with increased duodenal eosinophilia independent of Helicobacter pylori infection. Alimentary pharmacology & therapeutics. 2023 Jul;58(1):134-6.

Zamani M, Alizadeh-Tabari S, Chan WW, Talley NJ. Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2023;118(12):2133-2143. doi:10.14309/ajg.0000000000002411

Zand Irani M, Eslick GD, Brown G, Talley NJ. Letter: eosinophilic duodenitis and increased intraepithelial lymphocytes in rumination syndrome – more evidence. Aliment Pharmacol Ther. 2023;57(11):1353-1354. doi:10.1111/apt.17481

2022

Bar-Yishay I, Shahidi N, Gupta S, Vosko S, van Hattem WA, Schoeman S, Sidhu M, Tate DJ, Hourigan LF, Singh R, Moss A, Raftopoulos SC, Brown G, Zanati S, Heitman SJ, Lee EYT, Burgess N, Williams SJ, Byth K, Bourke MJ. “Outcomes of Deep Mural Injury After Endoscopic Resection: An International Cohort of 3717 Large Non-Pedunculated Colorectal Polyps”. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e139-e147. doi: 10.1016/j.cgh.2021.01.007. Epub 2021 Jan 8. PMID: 33422686.

Bruce J, Burns G, Soh WS, Nair PM, Sherwin S, Fan K, Dowling L, Goggins B, Koloski N, Potter M, Bollipo S, Foster R, Gan LT, Veysey M, Philpott D, Girardin S, Holtmann G, Kaiko G, Walker M, Talley NJ, Keely S. “Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsia”. Brain Behav Immun. 2022 Jan 

Brunt EM, Clouston AD, Goodman Z, Guy C, Kleiner DE, Lackner C, Tiniakos DG, Wee A, Yeh M, Leow WQ, Chng E, Ren Y, Boon Bee GG, Powell EE, Rinella M, Sanyal AJ,  Neuschwander-Tetri B, Younossi Z, Charlton M, Ratziu V, Harrison SA, Tai D, Anstee QM. “Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD”. J Hepatol. 2022 Jan 25:S0168-8278(22)00024-1. doi: 10.1016/j.jhep.2022.01.011. Epub ahead of print. PMID: 35090960.

Cronin O, Sidhu M, Shahidi N, Gupta S, O’Sullivan T, Whitfield A, Wang H, Kumar P, Hourigan LF, Byth K, Burgess NG, Bourke MJ. “A Comparison of the Morphology and Histopathology of Large Non-Pedunculated Colorectal Polyps in the Rectum and Colon: Implications for Endoscopic Treatment”. Gastrointest Endosc. 2022 Feb 24:S0016-5107(22)00161-4. doi: 10.1016/j.gie.2022.02.022. Epub ahead of print. PMID: 35219724.

Gibson PR, Halmos EP, So D, Yao CK, Varney JE, Muir JG. “Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey”. J Gastroenterol Hepatol. 2022 Jan 6. PMID: 34994019.

Jouffe C, Weger BD, Martin E, Atger F, Weger M, Gobet C, Ramnath D, Charpagne A, Morin-Rivron D, Powell EE, Sweet MJ, Masoodi M, Uhlenhaut NH, Gachon F. “Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease”. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2200083119. doi:  10.1073/pnas.2200083119. Epub 2022 Mar 1. PMID: 35238641.

Keshvari S, Genz B, Teakle N, Caruso M, Cestari MF, Patkar OL, Tse BWC, Sokolowski KA, Ebersbach H, Jascur J, MacDonald KPA, Miller G, Ramm GA, Pettit AR, Clouston AD, Powell EE, Hume DA, Irvine KM. “Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease.” Dis Model Mech. 2022 Feb 16:dmm.049387. doi: 10.1242/dmm.049387. Epub ahead of print. PMID: 35169835.

Knowles SR, Apputhurai P, Burgell RE, Keefer L. “Development and Validation of the Gastrointestinal Unhelpful Thinking Scale (GUTs): A Brief Self-Report Measure for Clinical and Research Settings”. Gastroenterol Nurs. 2022 Jan-Feb

Gracen L, Hayward KL, Aikebuse M, Williams S, Russell A, O’Beirne J, Powell EE, Valery PC. “An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.” Diabet Med. 2022 Jan 31:e14799. doi:  10.1111/dme.14799. Epub ahead of print. PMID: 35100462.

Mayr HL, Kelly JT, Macdonald GA, Russell AW, Hickman IJ. “Clinician perspectives of barriers and enablers to implementing the Mediterranean dietary pattern in routine care for coronary heart disease and type 2 diabetes: A qualitative interview study.”. J Acad Nutr Diet. 2022 Jan 28:S2212-2672(22)00043-0. doi:  10.1016/j.jand.2022.01.01

Prasad SS, Walker MWTalley NJ, Keely S, Kairuz T, Jones MP, Duncanson K. “Health care needs and perceptions of people living with inflammatory bowel disease in Australia: a mixed methods study”, Crohn’s & Colitis 360, 2022

Radford-Smith DE, Patel PJ, Irvine KM, Russell A, Siskind D, Anthony DC, Powell EE, Probert F. “Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism”. PLoS One. 2022 Jan 6;17(1):e0261555. doi: 10.1371/journal.pone.0261555. PMID: 34990473; PMCID: PMC8735618.

Shah A, Fairlie T, Brown G, Jones MP, Eslick G, Duncanson K, Thapar N, Keely S, Koloski N, Shahi M, Walker M, Talley NJ, Holtmann G. “Duodenal Eosinophils and Mast Cells in Functional dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies”. Clin Gastroenterol Hepatol . 2022 Feb

Shah A, Holtmann G.”Small intestinal bacterial overgrowth in inflammatory bowel disease”. Indian J Gastroenterol. 2022 Jan 15. doi: 10.1007/s12664-021-01235-y. Epub ahead of print. PMID: 35031976.

Valery PC, Powell EE. “Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review””. JHEP Rep. 2021 Nov 9;4(2):100393. doi: 10.1016/j.jhepr.2021.100393. PMID: 34984331; PMCID: PMC8693009.

Vollebregt PF, Burgell RE, Knowles CH, Scott SM. “Rectal Hyposensitivity Is an Important Pathophysiologic Mechanism in Patients With Constipation: Evidence From Large Observational Studies in Patients Referred for Anorectal Physiology Testing”. Am J Gastroenterol. 2022 Jan 25

Wang SE, Kendall BJ, Hodge AM, Dixon-Suen SC, Dashti SG, Makalic E, Williamson EM, Thomas RJS, Giles GG, English DR. “Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett’s esophagus in Australia”. Dis Esophagus. 2022 Jan 7;35(1):doab058. doi: 10.1093/dote/doab058. PMID: 34409990.

2021

Bolan S, Seshadri B, Grainge I, Talley NJ, Naidu R. “Gut microbes modulate bioaccessibility of lead in soil”.   Chemosphere. 2021 May;270:

Bolan S, Seshadri B, Keely S, Kunhikrishnan A, Bruce J, Grainge I, Talley NJ, Naidu R. “Bioavailability of arsenic, cadmium, lead and mercury as measured by intestinal permeability”.Sci Rep. Sci Rep. 2021 Jul 19.

Burns GL, Hoedt EC, Keely S.  “Spore-forming probiotics for functional dyspepsia”. Lancet Gastroenterol Hepatol. 2021 Aug 3

Duncanson KBurns GPryor JKeely S, Talley NJ. “Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia”. Nutrients. 2021 Mar 28

Gandhi A, Shah A, Jones MP, Koloski N, Talley NJ, Morrison M, Holtmann G. “Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis”. Gut Microbes. 2021 Jan-Dec;13(1)

Goggins BJ ,  Minahan K , Sherwin S,  Soh WS,  Pryor JBruce J, Liu G , Mathe A, Knight D, Horvat JC,  Walker MM, Keely S. “Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function”. Am J Physiol Gastrointest Liver Physiol . 2021 Apr 1

Gurusamy SR, Shah A, Talley NJ, Koloski N, Jones MP, Walker MM, Morrison M, Holtmann G. “Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis”.Am J Gastroenterol. 2021 May 1;116(5):935-942.

Gurusamy SR, Shah A, Talley NJ, Koloski N, Jones MP, Walker MM, Morrison M, Holtmann G. “Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis”. Am J Gastroenterol. 2021 May 1

Hoedt EC, Bongers RS, Bottacini F, Knol J, MacSharry J, van Sinderen D. “Bifidobacterium Transformation”. Methods Mol Biol. 2021

Hoedt EC, Bottacini F, Cash N, Bongers RS, van Limpt K, Ben Amor K, Knol J, MacSharry J, van Sinderen D. “Broad Purpose Vector for Site-Directed Insertional Mutagenesis in Bifidobacterium breve”.           Front Microbiol. 2021 Mar 23

Holtmann GJ, Huelsen A, Shah A, Hourigan LF, Morrison M. “Is a Fundamental Design Change for Gastrointestinal Endoscopes Required?” J Clin Gastroenterol. 2021 Jan;55(1):21-24.

Huelsen A, St John AT, Pandey R, Vokes DE, McMaster JJ, Walmsley RS, Holtmann GJ. “Structured oropharynx, hypopharynx and larynx assessment during routine esophagogastroduodenoscopy improves detection of pre- and early cancerous lesions: a multicenter, comparative study”. Endosc Int Open. 2021 Feb;9(2)

Johnson KM, Fischer RT, Holtmann GJ, Shah A, Alrabadi L, Lewindon P. “Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis”.Hepatology. 2021 Feb 26.

Jones MP, Shah A, Ben-Jacob R, Talley NJ , Hansen T, Walker MM, Gray M, Koloski N, Holtmann G. “Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases”. Neurogastroenterol Motil. 2021 Jan 29

Jones MP, Walter S, Talley NJ , Walker MM, Holtmann GJ, Shah A, D’Amato M, Agréus L, Andreasson A. “Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes”.Eur J Gastroenterol Hepatol. 2021 Jun 17.

Klaassen T, Smeets FGM, Vork L, Tack J, Talley NJ, Simrén M, Aziz Q, Ford AC, Kruimel JW, Conchillo JM, Leue C, Masclee AAM, Keszthelyi D. “Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia”.Neurogastroenterol Motil. 2021 May 2

Koloski N, Jones M, Walker MM, Keely S, Holtmann G, Talley NJ. “Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians”. Aliment Pharmacol Ther. 2021 Jul 11.

Kutyla MJ, Gray MA, von Hippel C, Hourigan LF, Kendall BJ, Whaley AJ, O’Connor S, Holtmann GJ. “Improving the Quality of Bowel Preparation: Rewarding Patients for Success or Intensive Patient Education?” Dig Dis. 2021;39(2)

Mazzoleni DS, Mazzoleni F, Mazzoleni LE, Francesconi CFM, Milbradt TC, Uchoa DM, Birnfeld HR, Andrighetto LV, Ries SADS, Simon D, Talley NJ. “Helicobacter pylori and other factors in recurrent aphthous stomatitis: A cross-sectional study”. Oral Dis. 2021 Jan 1

Meeusen V, Kim N, Elson J, Ma R, Newman F, Bendeich J, Holtmann G. “Patient Positioning Guidelines for Gastrointestinal Endoscopic Procedures”. Gastroenterol Nurs. 2021 May-Jun 01;44(3):185-191.

Moshiree B, Talley NJ. “Functional dyspepsia: A critical appraisal of the European consensus from a global perspective”. Neurogastroenterol Motil. Neurogastroenterol Motil. 2021 Aug 1

Prasad SS, Duncanson K, Keely S, Talley NJ, Kairuz T, Holtmann GJ, Shah A, Walker MM. “Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review”. Pharmacy (Basel). 2020 Nov 2;8

Ronkainen J, Aro P, Jones M, Walker MM, Agréus L, Andreasson A, Talley NJ.“Duodenal eosinophilia and the link to anxiety: A population-based endoscopic study”. Neurogastroenterol Motil. 2021 Mar 9

Staudacher HM, Nevin AN, Duff C, Kendall BJ, Holtmann GJ. “Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia”. Neurogastroenterol Motil. 2021 Apr 12

Talley NJ, Alexander JL, Walker MM, Jones MP, Hugerth LW, Engstrand L, Agreus L, Powell N, Andreasson A. “Ileocolonic histopathological and microbial alterations in the irritable bowel syndrome: A nested community case-control study”. CTG.

Talley NJ, Powell N, Walker MM, Jones MP, Ronkainen J, Forsberg A, Kjellström L, Hellström PM, Aro P, Wallner B, Agréus L, Andreasson A. “Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies”.      .

Talley NJ, Walker MM, Jones M, Keely S, Koloski N, Cameron R, Fairlie T, Burns G, Shah A, Hansen T, Harris G, Holtmann G. “Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial”.Aliment Pharmacol Ther. 2021 Jun;53(12):1332-1333

Talley NJ, Zand Irani M. “Optimal management of severe symptomatic gastroesophageal reflux disease”. J Intern Med. 2021 Feb

Teh JJ, Berendsen EM, Hoedt EC, Kang S, Zhang J, Zhang F, Liu Q, Hamilton AL, Wilson-O’Brien A, Ching J, Sung JJY, Yu J, Ng SC, Kamm MA, Morrison M. “Novel strain-level resolution of Crohn’s disease mucosa-associated microbiota via an ex vivo combination of microbe culture and metagenomic sequencing”. ISME J. 2021 May 25

Zand Irani M, Talley NJ, Ronkainen J, Aro P, Andreasson A, Agreus L, Vieth M, Jones MP, Walker MM. “Neutrophils, eosinophils, and intraepithelial lymphocytes in the squamous esophagus in subjects with and without gastroesophageal reflux symptoms”. Human Pathology    . 2021 Jun 25

2020

Andreasson A, Talley NJ, Walker MM, Jones MP, Platts LG, Wallner B, Kjellström L, Hellström PM, Forsberg A, Agréus L. “An Increasing Incidence of Upper Gastrointestinal Disorders Over 23 Years: A Prospective Population-Based Study in Sweden”. Am J Gastroenterol. 2020 Oct 7

Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. “Functional gastrointestinal disorders: advances in understanding and management”. Lancet. 2020 Nov 21

Carroll GM, Burns GL, Petit JA, Walker MM, Mathe A, Smith SR, Keely S, Pockney PG. “Does postoperative inflammation or sepsis generate neutrophil extracellular traps that influence colorectal cancer progression? A systematic review”. Surgery Open Science. 2020 Apr 1;2(2):57-69.

Chonwerawong M, Ferrand J, Chaudhry HM, Higgins C, Walker MM, Bhathal PS, Dev A, Moore GT, Sievert W, Jenkins BJ, D’Elios MM. “Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue”. Gastroenterology. 2020 Mar 10.

Choung RS, Saito YA, Schleck CD, Harmsen WS, Zinsmeister AR, Murray JA, Talley NJ. “The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux over 20 years: a U.S. Population-based Study”. Mayo Clinic Proceedings      

DeZoeten EF, Battista KD, Colson SB, Lovell MA, Kessler BE, Isfort RW, Fennimore BP, Onyiah JC, Kao DJ, Yeckes A, Keely S. “Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease”. Hypoxia. 2020;8:1.

Griffin N, Rowe CW, Gao F, Jobling P, Wills V, Walker MM, Faulkner S, Hondermarck H. “Clinicopathological Significance of Nerves in Esophageal Cancer”. Am J Pathol. 2020 May 29

Gwee KA, Holtmann G, Tack J, Suzuki H, Liu J, Xiao Y, Chen MH, Hou X, Wu DC, Toh C, Lu F, Tang XD. “Herbal medicines in functional dyspepsia-Untapped opportunities not without risks”. Neurogastroenterol Motil. 2021 Feb;33(2)

Keely S, Talley NJ. “Duodenal bile acids as determinants of intestinal mucosal homeostasis and disease”. Neuro Gastro Motil, In Press DOI:10.1111/nmo.13854

Koloski N, Holtmann G, Talley NJ. “Is there a causal link between psychological disorders and functional gastrointestinal disorders?” Expert Rev Gastroenterol Hepatol. 2020 Nov;14(11)

Koloski NA, Jones M, Walker MM, Holtmann G, Talley NJ. “Functional dyspepsia is associated with lower exercise levels: A population-based study”. United European Gastroenterology Journal. 2020 Mar 30:2050640620916680.

Kutyla MJ, O’Connor S, Hourigan LF, Kendall B, Whaley A, Meeusen V, Holtmann GJ. “An Evidence-based Approach Towards Targeted Patient Education to Improve Bowel Preparation for Colonoscopy.” J Clin Gastroenterol. 2020 Sep;54(8)

Liu G, Baird AW, Parsons MJ, Fan K, Skerrett Byrne DA, Nair PM, Makanyengo S, Chen J, Neal R, Goggins BJ, Tay H. “Platelet activating factor receptor acts to limit colitis induced liver inflammation”. The FASEB Journal. 2020 Apr 15.

Makanyengo SO, Carroll GM, Goggins BJ, Smith SR, Pockney PG, Keely S. “Systematic Review on the Influence of Tissue Oxygenation on Gut Microbiota and Anastomotic Healing”. J Surg Res.2020 May

Potter M, Jones MP, Walker MM, Koloski NA, Keely S, Holtmann G, Talley NJ. “Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia”. Med J Aust. 2020 Feb. Epub 2020 Jan 7.

Potter MD, Hunt JS, Walker MM, Jones M, Liu C, Weltman M, Talley NJ. “Duodenal eosinophils as predictors of symptoms in coeliac disease: a comparison of coeliac disease and non-coeliac dyspeptic patients with controls”. Scand J Gastroenterol.[published online ahead of print, 2020 Jun 13].

Potter MDE, Duncanson K, Jones MP, Walker MM, Keely S, Talley NJ. “Wheat Sensitivity and Functional Dyspepsia: A Pilot, Double-Blind, Randomized, Placebo-Controlled Dietary Crossover Trial with Novel Challenge Protocol”. Nutrients. 2020 Jun 30

Prasad SS, Duncanson K, Keely S, Talley NJ, Kairuz T, Holtmann GJ, Shah A, Walker MM. “A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review.” Pharmacy (Basel). 2020 Nov 2;8(4):204.

Prasad SS, Keely S, Talley NJ, Kairuz T, Walker MM. “Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease”. Pharmacy (Basel). 2020 Apr 17;8(2). pii: E68.

Shah A, Jones MP, Holtmann GJ. Indian J Gastroenterol. “Basics of meta-analysis.” Epub 2020 Oct

Shah A, Macdonald GA, Morrison M, Holtmann G. “Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework”. Am J Gastroenterol. 2020 Mar 25.

Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ. “Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies”. Am J Gastroenterol. 2020 Feb

Shah A, Talley NJ, Koloski N, Macdonald GA, Kendall BJ, Shanahan ER, Walker MM, Keely S, Jones MP, Morrison M, Holtmann GJ. “Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease.” Aliment Pharmacol Ther. 2020 May 15

Shukla SD, Walters EH, Simpson JL, Keely S, Wark PAB, O’Toole RF, Hansbro PM. “Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease”. Respirology. 2020 Jan;25

Sokulsky LA, Goggins B, Sherwin S, Eyers F, Kaiko GE, Board PG, Keely S, Yang M, Foster PS. “GSTO1-1 is an upstream suppressor of M2 macrophage skewing and HIF-1α-induced eosinophilic airway inflammation”. Clin Exp Allergy.  2020 Feb 12

Talley NJ, Holtmann GJ, Jones M, Koloski N, Walker MM, Burns G, Potter MDE, Shah A, Keely S. “Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.” Gut. 2020 Sep;69(9)

Talley NJ, Irani M, Keely S. “Bacterial therapy for irritable bowel syndrome”. The lancet. Gastroenterology & Hepatology. 2020 Apr 8.

Talley NJ. “What causes functional gastrointestinal disorders? A proposed disease model”. American Journal of Gastroenterology. 2020 Jan 1;115(1):41-8.

Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. “Duodenal inflammation: an emerging target for functional dyspepsia?”. Expert Opinion on Therapeutic Targets. 2020 Jun 2;24(6):511-23.

Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T. “Novel concepts in the pathophysiology and treatment of functional dyspepsia”. Gut. 2020 Mar 1;69(3):591-600.

2019

Kupcinskas J, Strate LL, Bassotti G, Torti G, Herszènyi L, Malfertheiner P, Cassieri C, Walker MM, Tursi A. “Pathogenesis of Diverticulosis and Diverticular Disease”. J Gastrointestin Liver Dis. 2019 Dec 19

Stollman N, Picchio M, Biondo S, Lahat A, Dumitrascu DL, Regula J, Walker MM.  “Critical Issues on Diverticular Disease”. J Gastrointestin Liver Dis. 2019 Dec 19

Talley NJ. “Allergies and Irritable Bowel Syndrome”. Gastroenterol Hepatol (N Y). 2019 Nov

Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M, Barbara G, Bassotti G, Binda GA, Biondi A, Biondo S, Cassieri C, Crucitti A, Dumitrascu DL, Elisei W, Escalante R, Herszènyi L, Kruis W, Kupcinskas J, Lahat A, Lecca PG, Maconi G, Malfertheiner P, Mazzari A, Mearìn F, Milosavljeviċ T, Nardone G, Chavez De Oliveira E, Papa A, Papagrigoriadis S, Pera M, Persiani R, Picchio M, Regula J, Štimac D, Stollman N, Strate LL, Walker MM. “DICA International Group.  The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study”. J Gastrointestin Liver Dis. 2019 Dec 19

Tursi A, Brandimarte G, Di Mario F, Lanas A, Scarpignato C, Bafutto M, Barbara G, Bassotti G, Binda GA, Biondi A, Biondo S, Cambiè G, Cassieri C, Crucitti A, Dumitrascu DL, Elisei W, Escalante R, Herszènyi L, Kruis W, Kupcinskas J, Lahat A, Lecca PG, Maconi G, Malfertheiner P, Mazzari A, Mearìn F, Milosavljeviċ T, Nardone G, Chavez De Oliveira E, Papa A, Papagrigoriadis S, Pera M, Persiani R, Picchio M, Regula J, Štimac D, Stollman N, Strate LL, Violi A, Walker MM. “International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease”. J Gastrointestin Liver Dis. 2019 Dec 19

Walker MM, Talley NJ. “Functional Dyspepsia in the Elderly”. Curr Gastroenterol Rep. 2019 Nov

 

 

 For conference poster presentations, click here.

Menu